Related references
Note: Only part of the references are listed.Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction (from the VCU-Alpha 1-RT Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Iain B. McInnes et al.
LANCET (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Acute-Phase Protein α1-Antitrypsin-A Novel Regulator of Angiopoietin-like Protein 4 Transcription and Secretion
Eileen Frenzel et al.
JOURNAL OF IMMUNOLOGY (2014)
Secukinumab failure in Crohn's disease: the yeast connection?
Jean Frederic Colombel et al.
GUT (2013)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Engagement of Fatty Acids With Toll-like Receptor 2 Drives Interleukin-1β Production via the ASC/Caspase 1 Pathway in Monosodium Urate Monohydrate Crystal-Induced Gouty Arthritis
Leo A. B. Joosten et al.
ARTHRITIS AND RHEUMATISM (2010)
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
Ivona Aksentijevich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
